ASTRAZENECA PLC 13D and 13G filings for Pieris Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-10 10:22 am Unchanged | 2022-12-31 | 13G | Pieris Pharmaceuticals, Inc. PIRS | ASTRAZENECA PLC | 44,803 4.800% | 0 (Unchanged) | Filing |
| 2021-04-07 5:37 pm Purchase | 2021-04-01 | 13G | Pieris Pharmaceuticals, Inc. PIRS | ASTRAZENECA PLC | 44,803 5.660% | 44,803 (New Position) | Filing |